PHC Holdings Corporation (2GY.F)
Frankfurt · EUR · Healthcare · Medical Devices
€7.40 (+6.47%) as of
Key statistics
- Market cap
- 940.61M
- P/E (TTM)
- 18.97
- EPS (TTM)
- 0.39
- Dividend yield
- 3.37%
- 52-week range
- 4.96 – 9.20
- Beta
- 0.72
- Revenue (TTM)
- 371.22B
- Profit margin
- 2.47%
- Volume
- 600.00
About PHC Holdings Corporation
PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management, Healthcare Solutions, and Diagnostics & Life Sciences. It offers precision anatomical pathology for cancer, including tissue processors, digital pathology, and histology consumables; cell growth and preservation, such as CFC-free ultra-low temperature freezers, CO2 incubators, and live cell metabolic analyzer and cell expansion bioreactor system; and diagnostic testing comprising clinical testing, diagnostic reagents, and digital diabetes management solutions. The company also provides patient record and billing solutions, which include electronic medical record systems and receipt systems, systems for pharmacies, and wellness and prevention; diabetes management technology, such as blood and continuous glucose monitoring systems; and medical device and drug delivery comprising contract development and manufacturing services, drug delivery systems, and digital health. It serves patients, healthcare professionals, and researchers. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. PHC Holdings Corporation was founded in 1948 and is headquartered in Chiyoda, Japan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Chiyoda, Japan
- Employees
- 8,647
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.